Global DNA Repair Drugs Market Research Report 2020


The global DNA Repair Drugs market is valued at US$ 513 million in 2020 is expected to reach US$ 1683.5 million by the end of 2026, growing at a CAGR of 18.4% during 2021-2026.
This report focuses on DNA Repair Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall DNA Repair Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the DNA Repair Drugs market is segmented into
    PARP Inhibitors
    Other

Segment by Application
    Oncological
    Stroke

 Global DNA Repair Drugs Market: Regional Analysis
The DNA Repair Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the DNA Repair Drugs market report are:
North America
    U.S.
    Canada
Europe
    Germany
    France
    U.K.
    Italy
    Russia
Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
Latin America
    Mexico
    Brazil
    Argentina
Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E
Global DNA Repair Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global DNA Repair Drugs market include:
    4SC AG
    ARCAGY/ GINECO GROUP
    Bristol Myers Squibb
    British Columbia Cancer Agency
    Cambridge University Hospitals NHS Foundation Trust
    Genentech
    Georgetown University
    German Breast Group
    GlaxoSmithKline
    Jiangsu Hengrui Medicine
    Johnson & Johnson
    Jonsson Comprehensive Cancer Center
    Karyopharm Therapeutics
    KuDOS Pharmaceuticals
    National Health Service
    National Institutes of Health
    Tesaro
Table of Contents

1 DNA Repair Drugs Market Overview
    1.1 Product Overview and Scope of DNA Repair Drugs
    1.2 DNA Repair Drugs Segment by Type
        1.2.1 Global DNA Repair Drugs Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 PARP Inhibitors
        1.2.3 Other
    1.3 DNA Repair Drugs Segment by Application
        1.3.1 DNA Repair Drugs Sales Comparison by Application: 2020 VS 2026
        1.3.2 Oncological
        1.3.3 Stroke
    1.4 Global DNA Repair Drugs Market Size Estimates and Forecasts
        1.4.1 Global DNA Repair Drugs Revenue 2015-2026
        1.4.2 Global DNA Repair Drugs Sales 2015-2026
        1.4.3 DNA Repair Drugs Market Size by Region: 2020 Versus 2026

2 Global DNA Repair Drugs Market Competition by Manufacturers
    2.1 Global DNA Repair Drugs Sales Market Share by Manufacturers (2015-2020)
    2.2 Global DNA Repair Drugs Revenue Share by Manufacturers (2015-2020)
    2.3 Global DNA Repair Drugs Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers DNA Repair Drugs Manufacturing Sites, Area Served, Product Type
    2.5 DNA Repair Drugs Market Competitive Situation and Trends
        2.5.1 DNA Repair Drugs Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key DNA Repair Drugs Players (Opinion Leaders)

3 DNA Repair Drugs Retrospective Market Scenario by Region
    3.1 Global DNA Repair Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global DNA Repair Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America DNA Repair Drugs Market Facts & Figures by Country
        3.3.1 North America DNA Repair Drugs Sales by Country
        3.3.2 North America DNA Repair Drugs Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe DNA Repair Drugs Market Facts & Figures by Country
        3.4.1 Europe DNA Repair Drugs Sales by Country
        3.4.2 Europe DNA Repair Drugs Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific DNA Repair Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific DNA Repair Drugs Sales by Region
        3.5.2 Asia Pacific DNA Repair Drugs Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America DNA Repair Drugs Market Facts & Figures by Country
        3.6.1 Latin America DNA Repair Drugs Sales by Country
        3.6.2 Latin America DNA Repair Drugs Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa DNA Repair Drugs Sales by Country
        3.7.2 Middle East and Africa DNA Repair Drugs Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global DNA Repair Drugs Historic Market Analysis by Type
    4.1 Global DNA Repair Drugs Sales Market Share by Type (2015-2020)
    4.2 Global DNA Repair Drugs Revenue Market Share by Type (2015-2020)
    4.3 Global DNA Repair Drugs Price Market Share by Type (2015-2020)
    4.4 Global DNA Repair Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global DNA Repair Drugs Historic Market Analysis by Application
    5.1 Global DNA Repair Drugs Sales Market Share by Application (2015-2020)
    5.2 Global DNA Repair Drugs Revenue Market Share by Application (2015-2020)
    5.3 Global DNA Repair Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in DNA Repair Drugs Business
    6.1 4SC AG
        6.1.1 Corporation Information
        6.1.2 4SC AG Description, Business Overview and Total Revenue
        6.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 4SC AG Products Offered
        6.1.5 4SC AG Recent Development
    6.2 ARCAGY/ GINECO GROUP
        6.2.1 ARCAGY/ GINECO GROUP DNA Repair Drugs Production Sites and Area Served
        6.2.2 ARCAGY/ GINECO GROUP Description, Business Overview and Total Revenue
        6.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 ARCAGY/ GINECO GROUP Products Offered
        6.2.5 ARCAGY/ GINECO GROUP Recent Development
    6.3 Bristol Myers Squibb
        6.3.1 Bristol Myers Squibb DNA Repair Drugs Production Sites and Area Served
        6.3.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
        6.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Bristol Myers Squibb Products Offered
        6.3.5 Bristol Myers Squibb Recent Development
    6.4 British Columbia Cancer Agency
        6.4.1 British Columbia Cancer Agency DNA Repair Drugs Production Sites and Area Served
        6.4.2 British Columbia Cancer Agency Description, Business Overview and Total Revenue
        6.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 British Columbia Cancer Agency Products Offered
        6.4.5 British Columbia Cancer Agency Recent Development
    6.5 Cambridge University Hospitals NHS Foundation Trust
        6.5.1 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Production Sites and Area Served
        6.5.2 Cambridge University Hospitals NHS Foundation Trust Description, Business Overview and Total Revenue
        6.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Cambridge University Hospitals NHS Foundation Trust Products Offered
        6.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
    6.6 Genentech
        6.6.1 Genentech DNA Repair Drugs Production Sites and Area Served
        6.6.2 Genentech Description, Business Overview and Total Revenue
        6.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Genentech Products Offered
        6.6.5 Genentech Recent Development
    6.7 Georgetown University
        6.6.1 Georgetown University DNA Repair Drugs Production Sites and Area Served
        6.6.2 Georgetown University Description, Business Overview and Total Revenue
        6.6.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Georgetown University Products Offered
        6.7.5 Georgetown University Recent Development
    6.8 German Breast Group
        6.8.1 German Breast Group DNA Repair Drugs Production Sites and Area Served
        6.8.2 German Breast Group Description, Business Overview and Total Revenue
        6.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 German Breast Group Products Offered
        6.8.5 German Breast Group Recent Development
    6.9 GlaxoSmithKline
        6.9.1 GlaxoSmithKline DNA Repair Drugs Production Sites and Area Served
        6.9.2 GlaxoSmithKline Description, Business Overview and Total Revenue
        6.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 GlaxoSmithKline Products Offered
        6.9.5 GlaxoSmithKline Recent Development
    6.10 Jiangsu Hengrui Medicine
        6.10.1 Jiangsu Hengrui Medicine DNA Repair Drugs Production Sites and Area Served
        6.10.2 Jiangsu Hengrui Medicine Description, Business Overview and Total Revenue
        6.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 Jiangsu Hengrui Medicine Products Offered
        6.10.5 Jiangsu Hengrui Medicine Recent Development
    6.11 Johnson & Johnson
        6.11.1 Johnson & Johnson DNA Repair Drugs Production Sites and Area Served
        6.11.2 Johnson & Johnson DNA Repair Drugs Description, Business Overview and Total Revenue
        6.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.11.4 Johnson & Johnson Products Offered
        6.11.5 Johnson & Johnson Recent Development
    6.12 Jonsson Comprehensive Cancer Center
        6.12.1 Jonsson Comprehensive Cancer Center DNA Repair Drugs Production Sites and Area Served
        6.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Description, Business Overview and Total Revenue
        6.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.12.4 Jonsson Comprehensive Cancer Center Products Offered
        6.12.5 Jonsson Comprehensive Cancer Center Recent Development
    6.13 Karyopharm Therapeutics
        6.13.1 Karyopharm Therapeutics DNA Repair Drugs Production Sites and Area Served
        6.13.2 Karyopharm Therapeutics DNA Repair Drugs Description, Business Overview and Total Revenue
        6.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.13.4 Karyopharm Therapeutics Products Offered
        6.13.5 Karyopharm Therapeutics Recent Development
    6.14 KuDOS Pharmaceuticals
        6.14.1 KuDOS Pharmaceuticals DNA Repair Drugs Production Sites and Area Served
        6.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Description, Business Overview and Total Revenue
        6.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.14.4 KuDOS Pharmaceuticals Products Offered
        6.14.5 KuDOS Pharmaceuticals Recent Development
    6.15 National Health Service
        6.15.1 National Health Service DNA Repair Drugs Production Sites and Area Served
        6.15.2 National Health Service DNA Repair Drugs Description, Business Overview and Total Revenue
        6.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.15.4 National Health Service Products Offered
        6.15.5 National Health Service Recent Development
    6.16 National Institutes of Health
        6.16.1 National Institutes of Health DNA Repair Drugs Production Sites and Area Served
        6.16.2 National Institutes of Health DNA Repair Drugs Description, Business Overview and Total Revenue
        6.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.16.4 National Institutes of Health Products Offered
        6.16.5 National Institutes of Health Recent Development
    6.17 Tesaro
        6.17.1 Tesaro DNA Repair Drugs Production Sites and Area Served
        6.17.2 Tesaro DNA Repair Drugs Description, Business Overview and Total Revenue
        6.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.17.4 Tesaro Products Offered
        6.17.5 Tesaro Recent Development

7 DNA Repair Drugs Manufacturing Cost Analysis
    7.1 DNA Repair Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of DNA Repair Drugs
    7.4 DNA Repair Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 DNA Repair Drugs Distributors List
    8.3 DNA Repair Drugs Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global DNA Repair Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of DNA Repair Drugs by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of DNA Repair Drugs by Type (2021-2026)
    10.2 DNA Repair Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of DNA Repair Drugs by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of DNA Repair Drugs by Application (2021-2026)
    10.3 DNA Repair Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of DNA Repair Drugs by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of DNA Repair Drugs by Region (2021-2026)
    10.4 North America DNA Repair Drugs Estimates and Projections (2021-2026)
    10.5 Europe DNA Repair Drugs Estimates and Projections (2021-2026)
    10.6 Asia Pacific DNA Repair Drugs Estimates and Projections (2021-2026)
    10.7 Latin America DNA Repair Drugs Estimates and Projections (2021-2026)
    10.8 Middle East and Africa DNA Repair Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global DNA Repair Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global DNA Repair Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global DNA Repair Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key DNA Repair Drugs Manufacturers Covered in This Study Table 5. Global DNA Repair Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global DNA Repair Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global DNA Repair Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global DNA Repair Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market DNA Repair Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers DNA Repair Drugs Sales Sites and Area Served Table 11. Manufacturers DNA Repair Drugs Product Types Table 12. Global DNA Repair Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Repair Drugs as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key DNA Repair Drugs Players Table 16. Global DNA Repair Drugs Sales (K Units) by Region (2015-2020) Table 17. Global DNA Repair Drugs Sales Market Share by Region (2015-2020) Table 18. Global DNA Repair Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global DNA Repair Drugs Revenue Market Share by Region (2015-2020) Table 20. North America DNA Repair Drugs Sales by Country (2015-2020) (K Units) Table 21. North America DNA Repair Drugs Sales Market Share by Country (2015-2020) Table 22. North America DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America DNA Repair Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe DNA Repair Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe DNA Repair Drugs Sales Market Share by Country (2015-2020) Table 26. Europe DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe DNA Repair Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific DNA Repair Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific DNA Repair Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America DNA Repair Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America DNA Repair Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America DNA Repair Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa DNA Repair Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa DNA Repair Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country (2015-2020) Table 40. Global DNA Repair Drugs Sales (K Units) by Type (2015-2020) Table 41. Global DNA Repair Drugs Sales Share by Type (2015-2020) Table 42. Global DNA Repair Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global DNA Repair Drugs Revenue Share by Type (2015-2020) Table 44. Global DNA Repair Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global DNA Repair Drugs Sales (K Units) by Application (2015-2020) Table 46. Global DNA Repair Drugs Sales Market Share by Application (2015-2020) Table 47. Global DNA Repair Drugs Sales Growth Rate by Application (2015-2020) Table 48. 4SC AG DNA Repair Drugs Corporation Information Table 49. 4SC AG Description and Business Overview Table 50. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. 4SC AG Main Product Table 52. 4SC AG Recent Development Table 53. ARCAGY/ GINECO GROUP DNA Repair Drugs Corporation Information Table 54. ARCAGY/ GINECO GROUP Corporation Information Table 55. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. ARCAGY/ GINECO GROUP Main Product Table 57. ARCAGY/ GINECO GROUP Recent Development Table 58. Bristol Myers Squibb DNA Repair Drugs Corporation Information Table 59. Bristol Myers Squibb Corporation Information Table 60. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Bristol Myers Squibb Main Product Table 62. Bristol Myers Squibb Recent Development Table 63. British Columbia Cancer Agency DNA Repair Drugs Corporation Information Table 64. British Columbia Cancer Agency Corporation Information Table 65. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. British Columbia Cancer Agency Main Product Table 67. British Columbia Cancer Agency Recent Development Table 68. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Corporation Information Table 69. Cambridge University Hospitals NHS Foundation Trust Corporation Information Table 70. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Cambridge University Hospitals NHS Foundation Trust Main Product Table 72. Cambridge University Hospitals NHS Foundation Trust Recent Development Table 73. Genentech DNA Repair Drugs Corporation Information Table 74. Genentech Corporation Information Table 75. Genentech DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Genentech Main Product Table 77. Genentech Recent Development Table 78. Georgetown University DNA Repair Drugs Corporation Information Table 79. Georgetown University Corporation Information Table 80. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Georgetown University Main Product Table 82. Georgetown University Recent Development Table 83. German Breast Group DNA Repair Drugs Corporation Information Table 84. German Breast Group Corporation Information Table 85. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. German Breast Group Main Product Table 87. German Breast Group Recent Development Table 88. GlaxoSmithKline DNA Repair Drugs Corporation Information Table 89. GlaxoSmithKline Corporation Information Table 90. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. GlaxoSmithKline Main Product Table 92. GlaxoSmithKline Recent Development Table 93. Jiangsu Hengrui Medicine DNA Repair Drugs Corporation Information Table 94. Jiangsu Hengrui Medicine Corporation Information Table 95. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Jiangsu Hengrui Medicine Main Product Table 97. Jiangsu Hengrui Medicine Recent Development Table 98. Johnson & Johnson DNA Repair Drugs Corporation Information Table 99. Johnson & Johnson Corporation Information Table 100. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Johnson & Johnson Main Product Table 102. Johnson & Johnson Recent Development Table 103. Jonsson Comprehensive Cancer Center DNA Repair Drugs Corporation Information Table 104. Jonsson Comprehensive Cancer Center Corporation Information Table 105. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Jonsson Comprehensive Cancer Center Main Product Table 107. Jonsson Comprehensive Cancer Center Recent Development Table 108. Karyopharm Therapeutics DNA Repair Drugs Corporation Information Table 109. Karyopharm Therapeutics Corporation Information Table 110. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Karyopharm Therapeutics Main Product Table 112. Karyopharm Therapeutics Recent Development Table 113. KuDOS Pharmaceuticals DNA Repair Drugs Corporation Information Table 114. KuDOS Pharmaceuticals Corporation Information Table 115. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. KuDOS Pharmaceuticals Main Product Table 117. KuDOS Pharmaceuticals Recent Development Table 118. National Health Service DNA Repair Drugs Corporation Information Table 119. National Health Service Corporation Information Table 120. National Health Service DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. National Health Service Main Product Table 122. National Health Service Recent Development Table 123. National Institutes of Health DNA Repair Drugs Corporation Information Table 124. National Institutes of Health Corporation Information Table 125. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. National Institutes of Health Main Product Table 127. National Institutes of Health Recent Development Table 128. Tesaro DNA Repair Drugs Corporation Information Table 129. Tesaro Corporation Information Table 130. Tesaro DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. Tesaro Main Product Table 132. Tesaro Recent Development Table 133. Sales Base and Market Concentration Rate of Raw Material Table 134. Key Suppliers of Raw Materials Table 135. DNA Repair Drugs Distributors List Table 136. DNA Repair Drugs Customers List Table 137. Market Key Trends Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 139. Key Challenges Table 140. Global DNA Repair Drugs Sales (K Units) Forecast by Type (2021-2026) Table 141. Global DNA Repair Drugs Sales Market Share Forecast by Type (2021-2026) Table 142. Global DNA Repair Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 143. Global DNA Repair Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 144. Global DNA Repair Drugs Sales (K Units) Forecast by Application (2021-2026) Table 145. Global DNA Repair Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 146. Global DNA Repair Drugs Sales (K Units) Forecast by Region (2021-2026) Table 147. Global DNA Repair Drugs Sales Market Share Forecast by Region (2021-2026) Table 148. Global DNA Repair Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 149. Global DNA Repair Drugs Revenue Market Share Forecast by Region (2021-2026) Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Picture of DNA Repair Drugs Figure 2. Global DNA Repair Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. PARP Inhibitors Product Picture Figure 4. Other Product Picture Figure 5. Global DNA Repair Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 6. Oncological Figure 7. Stroke Figure 8. Global DNA Repair Drugs Market Size 2015-2026 (US$ Million) Figure 9. Global DNA Repair Drugs Sales Capacity (K Units) (2015-2026) Figure 10. Global DNA Repair Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 11. DNA Repair Drugs Sales Share by Manufacturers in 2020 Figure 12. Global DNA Repair Drugs Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by DNA Repair Drugs Revenue in 2019 Figure 14. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global DNA Repair Drugs Sales Market Share by Region (2015-2020) Figure 16. Global DNA Repair Drugs Sales Market Share by Region in 2019 Figure 17. Global DNA Repair Drugs Revenue Market Share by Region (2015-2020) Figure 18. Global DNA Repair Drugs Revenue Market Share by Region in 2019 Figure 19. North America DNA Repair Drugs Sales Market Share by Country in 2019 Figure 20. North America DNA Repair Drugs Revenue Market Share by Country in 2019 Figure 21. U.S. DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe DNA Repair Drugs Sales Market Share by Country in 2019 Figure 26. Europe DNA Repair Drugs Revenue Market Share by Country in 2019 Figure 27. Germany DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 30. France DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific DNA Repair Drugs Sales Market Share by Region in 2019 Figure 38. Asia Pacific DNA Repair Drugs Revenue Market Share by Region in 2019 Figure 39. China DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. China DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. India DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America DNA Repair Drugs Sales Market Share by Country in 2019 Figure 62. Latin America DNA Repair Drugs Revenue Market Share by Country in 2019 Figure 63. Mexico DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa DNA Repair Drugs Sales Market Share by Country in 2019 Figure 70. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country in 2019 Figure 71. Turkey DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E DNA Repair Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E DNA Repair Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of DNA Repair Drugs by Type (2015-2020) Figure 78. Sales Market Share of DNA Repair Drugs by Type in 2019 Figure 79. Revenue Share of DNA Repair Drugs by Type (2015-2020) Figure 80. Revenue Market Share of DNA Repair Drugs by Type in 2019 Figure 81. Global DNA Repair Drugs Sales Growth by Type (2015-2020) (K Units) Figure 82. Global DNA Repair Drugs Sales Market Share by Application (2015-2020) Figure 83. Global DNA Repair Drugs Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of DNA Repair Drugs by Application (2015-2020) Figure 85. Global Revenue Share of DNA Repair Drugs by Application in 2020 Figure 86. 4SC AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. ARCAGY/ GINECO GROUP Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. British Columbia Cancer Agency Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Cambridge University Hospitals NHS Foundation Trust Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Genentech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Georgetown University Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. German Breast Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Jiangsu Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Jonsson Comprehensive Cancer Center Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Karyopharm Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. KuDOS Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. National Health Service Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. National Institutes of Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Tesaro Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Price Trend of Key Raw Materials Figure 104. Manufacturing Cost Structure of DNA Repair Drugs Figure 105. Manufacturing Process Analysis of DNA Repair Drugs Figure 106. DNA Repair Drugs Industrial Chain Analysis Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Porter's Five Forces Analysis Figure 110. North America DNA Repair Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. North America DNA Repair Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Europe DNA Repair Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 113. Europe DNA Repair Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Latin America DNA Repair Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 115. Latin America DNA Repair Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Middle East and Africa DNA Repair Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 117. Middle East and Africa DNA Repair Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Asia Pacific DNA Repair Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 119. Asia Pacific DNA Repair Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Gelatin Capsule Market Research Report Analysis and Forecasts to 2025

Going by the estimates of reliable sources, the global gelatin capsule market is presumed to expand with 6.6% CAGR during 2020-2025, hence crossing a market valuation of USD 5012 million by the year 2025. Surging occurrence of lifestyle disorders lik...

Polymers for Implantable Medical Devices Market Size, Share | Industry Analysis Report, 2025

As per credible estimates, the global polymers for implantable medical devices market was worth USD 992.9 million in the year 2019 and is expected to grow with a CAGR of 3.6% during 2020-2025, hence reaching USD 1143.3 million by the end of study per...

Other Reports by QY Research

Global Sartans Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

SUMMARY Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 ...

Global Telehealth Systems Key Trends and Opportunities to 2026

Telehealth is the distribution of health-related services and information via electronic information and telecommunication technologies. It allows long-distance patient and clinician contact, care, advice, reminders, education, intervention, monitori...

Global Electric Capacitors Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

SUMMARY Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 ...

Global 5G Fiber Optic Cables Market Insights, Forecast to 2026

Summary Fiber optic cable is a cable containing one or more optical fibers that are used to carry light. The optical fiber elements are typically individually coated with plastic layers and contained in a protective tube suitable for the environment...

Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size, Status and Forecast 2020-2026

Summary The main levels of BTK inhibitor are divided into Irreversible Inhibitor and Reversible Inhibitor according to therapeutic options. Bruton tyrosine kinase (BTK) is a key kinase in the signaling pathway of B cell antigen receptor (BCR). Since...

Publisher: QY Research